Raymond Kiu

Dr. Raymond Kiu

Quadram Institute Bioscience
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2018 in Emerging Microbes & Infections
Verified
Journal Article
Open access
Raymond KiuRaymond Kiu
Raymond Kiu
LHLindsay Hall
Lindsay Hall
Clostridium perfringens, a rapid-growing pathogen known to secrete an arsenal of >20 virulent toxins, has been associated with intestinal diseases in both animals and humans throughout the past cen...

1 August 2020 in Cell Reports Medicine
Verified
Journal Article
Open access
CACristina Alcon-Giner
Cristina Alcon-Giner
MDMatthew J. Dalby
Matthew J. Dalby
SCShabhonam Caim
Shabhonam Caim
JKJennifer Ketskemety
Jennifer Ketskemety
ASAlex Shaw
Alex Shaw
LHLindsay Hall
Lindsay Hall
Supplementation with members of the early-life microbiota as “probiotics” is increasingly used in attempts to beneficially manipulate the preterm infant gut microbiota. We performed a large observational longitudinal study comprising two preterm groups: 101 infants orally supplemented with Bifidobacterium and Lactobacillus (Bif/Lacto) and 133 infants non-supplemented (control) matched by age, sex, and delivery method. 16S rRNA gene profiling on fecal samples (n = 592) showed a predominance of Bifidobacterium and a lower abundance of pathobionts in the Bif/Lacto group. Metabolomic analysis showed higher fecal acetate and lactate and a lower fecal pH in the Bif/Lacto group compared to the control group. Fecal acetate positively correlated with relative abundance of Bifidobacterium, consistent with the ability of the supplemented Bifidobacterium strain to metabolize human milk oligosaccharides into acetate. This study demonstrates that microbiota supplementation is associated with a Bifidobacterium-dominated preterm microbiota and gastrointestinal environment more closely resembling that of full-term infants.

12 December 2017 in Frontiers in Microbiology
Verified
Journal Article
Open access
Raymond KiuRaymond Kiu
Raymond Kiu
SCShabhonam Caim
Shabhonam Caim
SASarah Alexander
Sarah Alexander
PPPurnima Pachori
Purnima Pachori
LHLindsay Hall
Lindsay Hall
Clostridium perfringens is an important cause of animal and human infections, however information about the genetic makeup of this pathogenic bacterium is currently limited. In this study, we sought to understand and characterise the genomic variation, pangenomic diversity, and key virulence traits of 56 C. perfringens strains which included 51 public, and 5 newly sequenced and annotated genomes using Whole Genome Sequencing. Our investigation revealed that C. perfringens has an “open” pangenome comprising 11667 genes and 12.6% of core genes, identified as the most divergent single-species Gram-positive bacterial pangenome currently reported. Our computational analyses also defined C. perfringens phylogeny (16S rRNA gene) in relation to some 25 Clostridium species, with C. baratii and C. sardiniense determined to be the closest relatives. Profiling virulence-associated factors confirmed presence of well-characterised C. perfringens-associated exotoxins genes including α-toxin (plc), enterotoxin (cpe), and Perfringolysin O (pfo or pfoA), although interestingly there did not appear to be a close correlation with encoded toxin type and disease phenotype. Furthermore, genomic analysis indicated significant horizontal gene transfer events as defined by presence of prophage genomes, and notably absence of CRISPR defence systems in >70% (40/56) of the strains. In relation to antimicrobial resistance mechanisms, tetracycline resistance genes (tet) and anti-defensins genes (mprF) were consistently detected in silico (tet: 75%; mprF: 100%). However, pre-antibiotic era strain genomes did not encode for tet, thus implying antimicrobial selective pressures in C. perfringens evolutionary history over the past 80 years. This study provides new genomic understanding of this genetically divergent multi-host bacterium, and further expands our knowledge on this medically and veterinary important pathogen.

25 May 2023 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
Raymond KiuRaymond Kiu
Raymond Kiu
ASAlexander G. Shaw
Alexander G. Shaw
KSKathleen Sim
Kathleen Sim
AAAntia Acuna-Gonzalez
Antia Acuna-Gonzalez
CPChristopher A. Price
Christopher A. Price
LHLindsay Hall
Lindsay Hall
Clostridium perfringensis an anaerobic toxin-producing bacterium associated with intestinal diseases, particularly in neonatal humans and animals. Infant gut microbiome studies have recently indicated a link betweenC. perfringensand the preterm infant disease necrotizing enterocolitis (NEC), with specific NEC cases associated with overabundantC. perfringenstermedC. perfringens-associated NEC (CPA-NEC). In the present study, we carried out whole-genome sequencing of 272C. perfringensisolates from 70 infants across 5 hospitals in the United Kingdom. In this retrospective analysis, we performed in-depth genomic analyses (virulence profiling, strain tracking and plasmid analysis) and experimentally characterized pathogenic traits of 31 strains, including 4 from CPA-NEC patients. We found that the gene encoding toxin perfringolysin O,pfoA, was largely deficient in a human-derived hypovirulent lineage, as well as certain colonization factors, in contrast to typicalpfoA-encoding virulent lineages. We determined that infant-associatedpfoA+strains caused significantly more cellular damage thanpfoA−strains in vitro, and further confirmed this virulence trait in vivo using an oral-challenge C57BL/6 murine model. These findings suggest both the importance ofpfoA+C. perfringensas a gut pathogen in preterm infants and areas for further investigation, including potential intervention and therapeutic strategies.

29 September 2017 in Genome Biology and Evolution
Verified
Journal Article
Open access
PDF file
Raymond KiuRaymond Kiu
Raymond Kiu
SCShabhonam Caim
Shabhonam Caim
CACristina Alcon-Giner
Cristina Alcon-Giner
GBGusztav Belteki
Gusztav Belteki
PCPaul Clarke
Paul Clarke
LHLindsay Hall
Lindsay Hall
Clostridium species (particularly Clostridium difficile, Clostridium botulinum, Clostridium tetani and Clostridium perfringens) are associated with a range of human and animal diseases. Several other species including Clostridium tertium, Clostridium cadaveris, and Clostridium paraputrificum have also been linked with sporadic human infections, however there is very limited, or in some cases, no genomic information publicly available. Thus, we isolated one C. tertium strain, one C. cadaveris strain and three C. paraputrificum strains from preterm infants residing within neonatal intensive care units and performed Whole Genome Sequencing (WGS) using Illumina HiSeq. In this report, we announce the open availability of the draft genomes: C. tertium LH009, C. cadaveris LH052, C. paraputrificum LH025, C. paraputrificum LH058, and C. paraputrificum LH141. These genomes were checked for contamination in silico to ensure purity, and we confirmed species identity and phylogeny using both 16S rRNA gene sequences (from PCR and in silico) and WGS-based approaches. Average Nucleotide Identity (ANI) was used to differentiate genomes from their closest relatives to further confirm speciation boundaries. We also analysed the genomes for virulence-related factors and antimicrobial resistance genes, and detected presence of tetracycline and methicillin resistance, and potentially harmful enzymes, including multiple phospholipases and toxins. The availability of genomic data in open databases, in tandem with our initial insights into the genomic content and virulence traits of these pathogenic Clostridium species, should enable the scientific community to further investigate the disease-causing mechanisms of these bacteria with a view to enhancing clinical diagnosis and treatment.

14 August 2025 in Nature Communications
Verified
Journal Article
Open access
Raymond KiuRaymond Kiu
Raymond Kiu
EDElizabeth M. Darby
Elizabeth M. Darby
CACristina Alcon-Giner
Cristina Alcon-Giner
AAAntia Acuna-Gonzalez
Antia Acuna-Gonzalez
ACAnny Camargo
Anny Camargo
LHLindsay Hall
Lindsay Hall
Preterm infants (300 metagenome-assembled genomes and obtained ~90 isolate genomes via targeted culturomics, allowing strain-level analysis. We also assessed ex vivo horizontal gene transfer (HGT) capacity of multidrug-resistant (MDR) Enterococcus using neonatal gut models. Here we show that probiotic supplementation significantly reduced antibiotic resistance gene prevalence, MDR pathogen load, and restored typical early-life microbiota profile. However, persistent MDR pathogens like Enterococcus , with high HGT potential, underscore the need for continued surveillance. Our findings underscore the complex interplay between antibiotics, probiotics, and HGT in shaping the neonatal microbiome and support further research into probiotics for antimicrobial stewardship in preterm populations.